Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Kessman v. Myriad Genetics et al
Case Number:
2:18-cv-00336
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
March 25, 2019
Myriad Genetics Ditches Medicare Overbilling Stock-Drop Suit
Myriad Genetics Inc. and its directors on Monday shook a proposed securities class action alleging a fraudulent billing of Medicare after a Utah federal judge ruled the suing investor failed to plead that the company's billing was illegal or even an outlier in the industry.
-
October 31, 2018
Myriad Genetics Tries To Ditch Billing Fraud Stock Drop Suit
Myriad Genetics Inc. and its directors asked a Utah federal judge to throw out a securities fraud class action against them on Tuesday, claiming that investors relied on an "armchair legal opinion" in their failure to adequately argue that the company illegally overbilled Medicare for its cancer testing services.
-
April 23, 2018
Genetics Co. Hid Cancer Test Overbilling, Investor Says
Myriad Genetics Inc. and its executives hid from shareholders that it was overbilling Medicare and Medicaid for a hereditary cancer test in a scheme that eventually drew the U.S. Department of Health and Human Services’ ire and caused the company's stock to slump, an investor in a proposed class action said in Utah federal court.